Cholesterol-lowering effects of oat β-glucan: A meta-analysis of randomized controlled trials1

American Journal of Clinical Nutrition

Volumn 100, Issue 6, 2014, Pages 1413-1421

  Whitehead, Anne ^a   Beck, Eleanor J ^b   Tosh, Susan ^c   Wolever, Thomas M S ^d  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

HDL cholesterol; LDL cholesterol; Meta analysis; Oats; Total cholesterol; Triglyceride; glucan

Indexed keywords

BETA GLUCAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OAT BETA GLUCAN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BETA-GLUCAN, (1-3)(1-4)-; PLANT EXTRACT;

ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES CONTROL; DIABETIC PATIENT; HUMAN; META ANALYSIS; OAT; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIACYLGLYCEROL BLOOD LEVEL; ADMINISTRATION AND DOSAGE; AVENA; BLOOD; CHEMISTRY; DIETARY FIBER;

AVENA; SCOPUS;

AVENA; BETA-GLUCANS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FIBER; HUMANS; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 84911383272     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.086108     Document Type: Article

References (50)

1. The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2011;32:1769-818.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. JAMA 2001;285:2486-97.
3. U.S. Food and Drug Administration (FDA). Health claims: soluble fiber from certain foods and the risk of coronary heart disease (CHD). Code of Federal Regulations Title 2; Section 101.81 [Internet]. Silver Spring (MD): FDA. 1997 [updated 2014 Sep 1; cited 2013 Nov 14]. Available from: www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=101.81.
4. Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada. Oat products and blood cholesterol lowering: summary of assessment of a health claim about oat products and blood cholesterol lowering [Internet]. Ottawa, Ontario: Health Canada. 2010 [cited 2013 Nov 14]. Available from: www.hc-sc.gc.ca/fn-An/label-etiquet/claims-reclam/assess-evalu/oat-Avoine-eng.php.
5. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J 2010;8:1885-1900.
6. Food Standards Australia New Zealand. Standard 1.2.7: Nutrition, health and related claims. Food Standards Gazette [Internet]. 2013;80. Available from: www.foodstandards.gov.au/code/changes/gazette/documents/gazette-138.pdf.
7. Ministry of Health Malaysia. Malaysian dietary guidelines-Key Message 14-make effective use of nutrition information on food labels [Internet]. Putrajaya (Malaysia): Ministry of Health Malaysia. 2010 [cited 2013 Nov 14]. Available from: www.moh.gov.my/images/gallery/Garispanduan/diet/km14.pdf.
8. Commission Regulation (EU) No 1160/2011 of 14 November 2011 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to the reduction of disease risk [Internet]. : Brussels (Belgium): Eur-Lex. 2011 [cited 2013 Nov 14]. Available from: http://eur-lex.europa.eu/JOHtml.do?uri=OJ:L:2011: 296:SOM:EN:HTML.
9. Ripsin CM, Keenan JM, Jacobs DR Jr., Elmer PJ, Welch RR, Van Horn L, Liu K, Turnbull WH, Thye FW, Kestin M, et al. Oat products and lipid lowering: a meta-Analysis. JAMA 1992;267:3317-25.
10. Erratum in: JAMA 1992;268:3074.
11. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-Analysis. Am J Clin Nutr 1999;69:30-42.
12. Kelly SAM, Summerbell CD, Byrnes A, Whittaker V, Frost G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev 2007;(2):CD005051.
13. Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, Duncan AM, Hart V, Lamarche B, Thomson BA, Duss R, Wood PJ. Physicochemical properties of oat b-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr 2010;92:723-32.
14. Biörklund M, van Rees A, Mensink RP, Ö nning G. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with b-glucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 2005;59:1272-81.
15. Lazaridou A, Biliaderis CG, Micha-Screttas M, Steele BR. A comparative study on structure-function relations of mixed-linkage (1/3), (1/4) linear b-D-glucans. Food Hydrocoll 2004;18:837-55.
16. Aman P, Rimsten L, Andersson R. Molecular weight distribution of b-glucan in oat-based foods. Cereal Chem 2004;81:356-60.
17. Beck EJ, Tapsell LC, Batterham MJ, Tosh SM, Huang XF. Oat betaglucan supplementation does not enhance the effectiveness of an energyrestricted diet in overweight women. Br J Nutr 2010;103:1212-22.
18. Charlton KE, Tapsell LC, Batterham MJ, O'Shea J, Thorne R, Beck E, Tosh SM. Effect of 6 weeks' consumption of b-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults. Br J Nutr 2012;107:1037-47.
19. European Food Safety Authority. Opinion of the panel on dietetic products, nutrition and allergies (NDA) on a request from the commission related to scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim. EFSA J 2007;5:530-574.
20. SAS Institute. The Mixed procedure. In: SAS/STAT 9.2 User's Guide. Cary (NC): SAS Institute; 2008.
21. van Houwelingen HC, Arends LR, Stijnen T. Tutorial in biostatistics: advanced methods in meta-Analysis: multivariate approach and metaregression. Stat Med 2002;21:589-624.
22. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-29.
23. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
24. Kabir M, Oppert JM, Vidal H, Bruzzo F, Fiquet C, Wursch P, Slama G, Rizkalla SW. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 2002;51:819-26.
25. Mäki KC, Beiseigel JM, Jonnalagadda SS, Gugger CK, Reeves MS, Farmer MV, Kaden VN, Rains TM. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods. J Am Diet Assoc 2010;110:205-14.
26. Anderson JW, Gilinsky NH, Deakins DA, Smith SF, Spencer O'Neal D, Dillon DW, Oeltgen PR. Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake. Am J Clin Nutr 1991;54:678-83.
27. Berg A, König D, Deibert P, Grathwohl D, Berg A, Baumstark MW, Franz I-W. Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk: a controlled randomized lifestyle intervention study. Ann Nutr Metab 2003;47:306-11.
28. Chen J, He J, Wildman RP, Reynolds K, Streiffer RH, Whelton PK. A randomized controlled trial of dietary fiber intake on serum lipids. Eur J Clin Nutr 2006;60:62-8.
29. Davidson MH, Dugan LD, Burns JH, Bova J, Story K, Drennan KB. The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran: a dose-controlled study. JAMA 1991;265:1833-9.
30. Davy BM, Davy KP, Ho RC, Beske SD, Davrath LR, Melby CL. Highfiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-Aged and older men. Am J Clin Nutr 2002;76:351-8.
31. Gerhardt AL, Gallo NB. Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans. J Nutr 1998;128:865-9.
32. Karmally W, Montez MG, Palmas W, Martinez W, Branstetter A, Ramakrishnan R, Holleran SF, Haffner SM, Ginsberg HN. Cholesterollowering benefits of oat-containing cereal in Hispanic Americans. JAm Diet Assoc 2005;105:967-70.
33. Liatis S, Tsapogas P, Chala E, Dimosthenopoulos C, Kyriakopolous K, Kapantais E, Katsilambros N. The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes. Diabete Metab 2009;35:115-20.
34. Pins JJ, Geleva D, Keenan JM, Frazel C, O'Connor PJ, Cherney LM. Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure control? J Fam Pract 2002;51:353-9.
35. Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL. Concentrated oat, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007;6:6-14.
36. Saltzman E, Das SK, Lichtenstein AH, Dallal GE, Corrales A, Schaefer EJ, Greenberg AS, Roberts SB. An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J Nutr 2001;131:1465-70.
37. Uusitupa MI, Ruuskanen E, Mäkinen E, Laitinen J, Toskala E, Kervinen K, Kesäniemi YA. A controlled study on the effect of betaglucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 1992;11:651-9.
38. Zhang J, Li L, Song P, Wang C, Man Q, Meng L, Cai J, Kurilich A. Randomized controlled trial of oatmeal consumption versus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia. Nutr J 2012;11:54-62.
39. Abrahamsson L, Göranzon H, Karlström B, Vessby B, Aman P. Metabolic effects of oat bran and wheat bran in healthy women. Scand J Nutr 1994;38:5-10.
40. Amundsen AL, Haugum B, Andersson H. Changes in serum cholesterol and sterol metabolites after intake of products enriched with an oat bran concentrate within a controlled diet. Scand J Nutr 2003;47:68-74.
41. Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P, Collins MW. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465-74.
42. Kerckhoffs DA, Hornstra G, Mensink RP. Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 2003;78:221-7.
43. Kestin M, Moss R, Clifton PM, Nestel PJ. Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am J Clin Nutr 1990;52: 661-6.
44. Kristensen M, Bügel S. A diet rich in oat bran improves blood lipids and hemostatic factors, and reduces apparent energy digestibility in young healthy volunteers. Eur J Clin Nutr 2011;65:1053-8.
45. Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 1996;96:1254-61.
46. Theuwissen E, Mensink RP. Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 2007;137:583-8.
47. Whyte JL, McArthur R, Topping D, Nestel P. Oat bran lowers plasma cholesterol levels in mildly hypercholesterolemic men. J Am Diet Assoc 1992;92:446-9.
48. Tosh SM, Brummer Y, Miller SS, Regand A, Defelice C, Duss R, Wolever TMS, Wood PJ. Processing affects the physicochemical properties of b-glucan in oat bran cereal. J Agric Food Chem 2010;58: 7723-30.
49. Bazzano LA, He J, Ogden LG, Loria CM, Whelton PK. Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Arch Intern Med 2003;163:1897-904.
50. Wolever TMS, Gibbs AL, Brand-Miller J, Duncan AM, Hart V, Lamarche B, Tosh SM, Duss R. Bioactive oat b-glucan reduces LDL cholesterol in Caucasians and non-Caucasians. Nutr J 2011; 10:130.